Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2018
Kinetics and Risk Factors of Relapse after Allogeneic Stem Cell Transplantation in Children with Leukemia: A Long-Term Follow-Up Single-Center StudyBlanca Molina, Marta Gonzalez Vicent, Blanca Herrero, et al.Leukemia Research|March 16, 2017
Donor age matters in T-cell depleted haploidentical hematopoietic stem cell transplantation in pediatric patients: Faster immune reconstitution using younger donorsMarta González-Vicent, Blanca Molina, Natalia Deltoro, et al.World Journal of Pediatrics : WJP|September 30, 2021
Comparison of clinical outcomes between unrelated single umbilical cord blood and "ex-vivo" T-cell depleted haploidentical transplantation in children with hematological malignanciesCarmen Gómez-Santos, Marta González-Vicent, Blanca Molina, et al.Journal of the Endocrine Society|December 19, 2022
Endocrine Sequelae in 157 Pediatric Survivors of Hematopoietic Stem Cell Transplantation (HSCT)María Güemes, Álvaro Martín-Rivada, Marta Bascuas Arribas, et al.Journal of Pediatric Hematology/Oncology|March 2, 2011
High-dose busulfan and cyclophosphamide as a conditioning regimen for autologous peripheral blood stem cell transplantation in childhood non-Hodgkin lymphoma patients: a long-term follow-up studyMaitane Andion, Blanca Molina, Marta Gonzalez-Vicent, et al.Journal of Clinical Apheresis|October 20, 2020
Plerixafor-based mobilization in pediatric healthy donors with unfavorable donor/recipient body weight ratio resulted in a better CD34+ collection yield: A retrospective analysisJosune Zubicaray, Eva Galvez, Elena Sebastian, et al.Pediatric Hematology and Oncology|February 9, 2011
High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk neuroblastoma patientsBlanca Molina, Laura Alonso, Marta Gonzalez-Vicent, et al.Leukemia & Lymphoma|July 15, 2021
Graft failure after "ex-vivo" T-cell depleted haploidentical transplantation in pediatric patients with high-risk hematological malignancies. A risk factors and outcomes analysisMiguel A Diaz, Ivan Lopez, Blanca Molina, et al.Frontiers in Immunology|November 19, 2019
Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ+ T-Cell Receptor and CD19+ Cell Depleted Grafts: High CD56dim/CD56bright NK Cell Ratio Early Following Transplantation Is Associated With Lower Relapse Incidence and Better OutcomeMiguel A Diaz, Josune Zubicaray, Blanca Molina, et al.Plos One|October 22, 2011
Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic studyDaniela Caronia, Ana Patiño-Garcia, Antonio Peréz-Martínez, et al.Pageof 4